Experiment: 7LHC

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D TOCSY	1.0 mM peptide	90% H2O/10% D2O	not defined	3.3	1 atm	298	Bruker AVANCE III HD 600
2	2D NOESY	1.0 mM peptide	90% H2O/10% D2O	not defined	3.3	1 atm	298	Bruker AVANCE III HD 600
3	2D TOCSY	1.0 mM peptide	100% D2O	not defined	3.3	1 atm	298	Bruker AVANCE III HD 600
4	2D 1H-15N HSQC	1.0 mM peptide	90% H2O/10% D2O	not defined	3.3	1 atm	298	Bruker AVANCE III HD 600
5	2D 1H-13C HSQC aliphatic	1.0 mM peptide	100% D2O	not defined	3.3	1 atm	298	Bruker AVANCE III HD 600
6	2d ECOSY	1.0 mM peptide	100% D2O	not defined	3.3	1 atm	298	Bruker AVANCE III HD 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III HD	600

NMR Refinement
Method	Details	Software
simulated annealing		CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CNS		Brunger A. T. et.al.
2	structure calculation	CYANA		Guntert, Mumenthaler and Wuthrich
3	chemical shift assignment	CcpNmr Analysis		CCPN
4	processing	TopSpin		Bruker Biospin

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.